The elusive ground glass opacity, revealed.

Autor: Korb ML; Division of Thoracic Surgery, The Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Burt BM; Division of Thoracic Surgery, The Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.

Publikováno v: Journal of thoracic disease [J Thorac Dis] 2018 Nov; Vol. 10 (Suppl 33), pp. S3828-S3830.

Characterizing the Utility and Limitations of Repurposing an Open-Field Optical Imaging Device for Fluorescence-Guided Surgery in Head and Neck Cancer Patients.

Autor: Moore LS; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Rosenthal EL; Department of Otolaryngology, Stanford University, Stanford, California elr@stanford.edu., Chung TK; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., de Boer E; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama.; Department of Surgery, University of Groningen, Groningen, The Netherlands., Patel N; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Prince AC; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Korb ML; Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Walsh EM; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Young ES; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama., Stevens TM; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama., Withrow KP; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Morlandt AB; Department of Oral and Maxillofacial Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and., Richman JS; Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Carroll WR; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Zinn KR; Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama., Warram JM; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2017 Feb; Vol. 58 (2), pp. 246-251. Date of Electronic Publication: 2016 Sep 01.

Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models.

Autor: Moore LS; Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama., de Boer E; Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama.; Department of Surgery, University Medical Center Groningen University of Groningen, Groningen, The Netherlands., Warram JM; Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Tucker MD; Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Carroll WR; Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Korb ML; Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Brandwein-Gensler MS; Department of Pathology, University at Buffalo, Buffalo, New York., van Dam GM; Department of Surgery, University Medical Center Groningen University of Groningen, Groningen, The Netherlands., Rosenthal EL; Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, California.

Publikováno v: Cancer medicine [Cancer Med] 2016 Jul; Vol. 5 (7), pp. 1526-34. Date of Electronic Publication: 2016 May 11.

Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.

Autor: Rosenthal EL; Division of Otolaryngology, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama. erosenthal@uabmc.edu., Warram JM; Division of Otolaryngology, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama., de Boer E; Division of Otolaryngology, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama. Department of Surgery, Division of Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Chung TK; Division of Otolaryngology, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Korb ML; Division of General Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Brandwein-Gensler M; Division of Anatomic Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama., Strong TV; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Schmalbach CE; Division of Otolaryngology, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Morlandt AB; Department of Oral and Maxillofacial Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Agarwal G; Division of Otolaryngology, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Hartman YE; Division of Otolaryngology, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Carroll WR; Division of Otolaryngology, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Richman JS; Division of General Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Clemons LK; Division of Otolaryngology, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama., Nabell LM; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Zinn KR; Division of Advanced Medical Imaging, Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Aug 15; Vol. 21 (16), pp. 3658-66. Date of Electronic Publication: 2015 Apr 22.

In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas.

Autor: de Boer E; Division of Otolaryngology, University of Alabama at Birmingham, USA.; Department of Surgery, University Medical Center Groningen, University of Groningen, The Netherlands., Warram JM; Division of Otolaryngology, University of Alabama at Birmingham, USA., Tucker MD; Division of Otolaryngology, University of Alabama at Birmingham, USA., Hartman YE; Division of Otolaryngology, University of Alabama at Birmingham, USA., Moore LS; Division of Otolaryngology, University of Alabama at Birmingham, USA., de Jong JS; Department of Pathology, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands., Chung TK; Division of Otolaryngology, University of Alabama at Birmingham, USA., Korb ML; Division of Otolaryngology, University of Alabama at Birmingham, USA., Zinn KR; Division of Advanced Medical Imaging, Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA., van Dam GM; Department of Surgery, Nuclear Medicine and Molecular Imaging and Intensive Care, University Medical Center Groningen, University of Groningen, The Netherlands., Rosenthal EL; Division of Otolaryngology, University of Alabama at Birmingham, USA., Brandwein-Gensler MS; Division of Anatomic Pathology, Department of Pathology, University of Alabama at Birmingham, USA.

Publikováno v: Scientific reports [Sci Rep] 2015 Jun 29; Vol. 5, pp. 10169. Date of Electronic Publication: 2015 Jun 29.